LAURA BOLAND: Open Payments
NPI 1912135245 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 29 payments from 11 companies in 2025. Trend: 2023 $680 · 2024 $881 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 1 | $214 |
| Amgen Inc. | 12 | $184 |
| Novo Nordisk Inc | 5 | $83 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Abbott Laboratories | 2 | $32 |
| Lilly USA, LLC | 2 | $31 |
| IBSA Pharma Inc. | 2 | $30 |
| Radius Health, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: TWIIST, TEPEZZA, Ozempic, EVENITY, REPATHA, REZDIFFRA, FREESTYLE LIBRE 3, JARDIANCE.
Industry payments across NY — which companies pay providers there.
